Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge for the development of food and farming industries worldwide. More Details
Adequate balance sheet and overvalued.
Share Price & News
How has Benchmark Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: BMK has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: BMK underperformed the UK Pharmaceuticals industry which returned 7.9% over the past year.
Return vs Market: BMK exceeded the UK Market which returned -13.2% over the past year.
Price Volatility Vs. Market
How volatile is Benchmark Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 year ago | Simply Wall StDoes Benchmark Holdings (LON:BMK) Have A Healthy Balance Sheet?
1 year ago | Simply Wall StBenchmark Holdings plc's (LON:BMK) Path To Profitability
1 year ago | Simply Wall StHow Should Investors Feel About Benchmark Holdings plc's (LON:BMK) CEO Pay?
Is Benchmark Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate BMK's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate BMK's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: BMK is unprofitable, so we can't compare its PE Ratio to the GB Pharmaceuticals industry average.
PE vs Market: BMK is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BMK's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BMK is good value based on its PB Ratio (1x) compared to the GB Pharmaceuticals industry average (4.3x).
How is Benchmark Holdings forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BMK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BMK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BMK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BMK's revenue (14% per year) is forecast to grow faster than the UK market (6.2% per year).
High Growth Revenue: BMK's revenue (14% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BMK's Return on Equity is forecast to be low in 3 years time (0%).
How has Benchmark Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BMK is currently unprofitable.
Growing Profit Margin: BMK is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BMK is unprofitable, and losses have increased over the past 5 years at a rate of 48.4% per year.
Accelerating Growth: Unable to compare BMK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BMK is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (9.8%).
Return on Equity
High ROE: BMK has a negative Return on Equity (-25.86%), as it is currently unprofitable.
How is Benchmark Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: BMK's short term assets (£139.6M) exceed its short term liabilities (£50.0M).
Long Term Liabilities: BMK's short term assets (£139.6M) do not cover its long term liabilities (£141.3M).
Debt to Equity History and Analysis
Debt Level: BMK's debt to equity ratio (31.6%) is considered satisfactory.
Reducing Debt: BMK's debt to equity ratio has increased from 0.07% to 31.6% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BMK has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: BMK has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 11% each year
What is Benchmark Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BMK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BMK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BMK's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BMK's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: BMK is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of BMK's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Trond Williksen (57 yo)
Mr. Trond Williksen serves as Chief Executive Officer and Director at Benchmark Holdings plc since June 01, 2020. He serves as the Executive Advisor at FSN Capital Partners AS since July 2019. Prior to thi ...
|CEO & Director||0.25yr||no data||0.027% |
|Co-Founder & Head of Benchmark Sustainability Science||no data||UK£14.18k||no data|
|CFO & Director||0.75yr||no data||0.040% |
|Director of Investor Relations & Corporate Development||no data||no data||no data|
|Company Secretary & Group Legal Counsel||1.33yrs||no data||no data|
|Group Marketing Director||1.92yrs||no data||no data|
|Head of People||no data||no data||no data|
|Group Lead of Key Account Management||2.67yrs||UK£271.00k||no data|
|Head of Advanced Nutrition||no data||no data||no data|
|Managing Director of Improve International||no data||no data||no data|
|Head of Knowledge Services||2.67yrs||no data||no data|
|Head of Animal Health||2.67yrs||no data||no data|
Experienced Management: BMK's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
|CEO & Director||0.25yr||no data||0.027% |
|CFO & Director||0.75yr||no data||0.040% |
|Independent Non-Executive Director||3.83yrs||UK£45.00k||0.013% |
|Independent Non-Executive Director||2.83yrs||UK£45.00k||0.12% |
|Non-Executive Director||1.5yrs||no data||no data|
|Senior Independent Non-Executive Director||no data||UK£45.00k||0.030% |
|Non-Executive Chairman||2.33yrs||UK£120.00k||0.45% |
|Independent Non-Executive Director||2.83yrs||UK£45.00k||0.052% |
Experienced Board: BMK's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: BMK insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.6%.
Benchmark Holdings plc's company bio, employee growth, exchange listings and data sources
- Name: Benchmark Holdings plc
- Ticker: BMK
- Exchange: AIM
- Founded: 2000
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: UK£300.448m
- Shares outstanding: 667.66m
- Website: https://www.benchmarkplc.com
Number of Employees
- Benchmark Holdings plc
- Benchmark House
- 8 Smithy Wood Drive
- South Yorkshire
- S35 1QN
- United Kingdom
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|BMK||AIM (London Stock Exchange AIM Market)||Yes||Ordinary Shares||GB||GBP||Dec 2013|
|BHCC.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Dec 2013|
|31B||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Dec 2013|
Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge for the development of food and farming industries worldwide. The company operates th ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/18 03:27|
|End of Day Share Price||2020/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.